This Privacy Policy explains how the Laboratory of Structure-Function Based Drug Design of the Institute of Biomedical Chemistry ("LSFBDD", "Way2Drug", "W2D Team", "we", "us" or "our") processes personal data in connection with the Way2Drug website and services available at way2drug.com.
This privacy policy sets out how the W2D Team uses and protects any information that you provide when using this website (way2drug.com). W2D Team is committed to ensuring that your privacy is protected and that your personal data is processed in accordance with applicable data protection legislation, including the Russian Federal Law No. 152-FZ "On Personal Data" and the Regulation (EU) 2016/679 (GDPR) to the extent applicable to international users.
W2D Team may update this policy from time to time by updating this page. We recommend checking this page periodically. Where changes are significant, we will notify you by email or a prominent notice on the website.
By using the Way2Drug platform and submitting any personal data through web forms, the user acknowledges this Policy and gives consent to the processing of their personal data under the terms described herein.
We may collect the following personal data:
Name and job title;
Contact information, including email address;
Usage data (e.g., pages visited, queries submitted to our online tools);
Technical data (IP address, browser type, pages visited, timestamps) may be collected automatically for analytics and security purposes.
Way2Drug does not intentionally use research inputs submitted to public web services, such as chemical structures, identifiers or protein sequences, to identify individual users.
Such inputs are processed only for the duration of the active session and are not retained after the request is completed, except where necessary for short-lived technical caching, security monitoring or legal obligations.
We process your personal data only when we have a lawful basis to do so. Depending on the context, this may include:
Consent - you have given clear consent to process your data for a specific purpose (e.g., subscribing to our newsletter);
Legitimate interest - processing is necessary for our legitimate scientific and operational interests;
Legal obligation - processing is required to comply with a legal obligation.
We use collected information for the following purposes:
Internal record keeping and service improvement;
Improving our web services and tools (PASS Online, GUSAR Online, DIGEP-Pred, CLC-Pred, SOMP, MetaPASS, DDI-Pred, and others);
Sending you relevant updates about Way2Drug services — only if you have explicitly opted in.
In accordance with Federal Law No. 152-FZ (as amended by Federal Law No. 23-FZ, effective 01.07.2025), personal data of Russian citizens is recorded, stored, and processed exclusively using databases located within the territory of the Russian Federation. Cross-border transfer of personal data, where applicable, is carried out in accordance with the exceptions specified in Article 12, Part 1 of Federal Law No. 152-FZ.
The database does not retain records of user search queries and does not collect any personal data; all queries are processed solely within the scope of the active user session.
Personal data of citizens of the Russian Federation is collected and initially recorded, systematised, accumulated, stored, updated and retrieved using databases located in the Russian Federation, as required by applicable Russian law.
We retain personal data only for as long as necessary to fulfil the purposes for which it was collected, or as required by law. Once no longer needed, data is securely deleted or anonymised.
Access - request a copy of the personal data we hold about you;
Rectification - request correction of inaccurate or incomplete data;
Erasure - request deletion of your personal data ("right to be forgotten");
Restriction - request that we limit how we use your data;
Objection - object to processing based on legitimate interests;
Withdrawal of consent - withdraw consent at any time without affecting the lawfulness of prior processing;
Data portability - receive your data in a structured, machine-readable format (where applicable)
To exercise any of these rights, please contact us. We will respond within 30 days.
The W2D Team implements appropriate technical and organizational measures to protect personal data against unauthorized access, disclosure, alteration, or destruction.
The Way2Drug platform uses HTTPS encryption for all data transmissions.
Our web services (PASS Online, GUSAR Online, DIGEP-Pred, CLC-Pred, SOMP, MetaPASS, DDI-Pred and others) are designed to support drug discovery and development using in silico methods: selecting promising compounds for synthesis and biological testing, filtering drug candidates with potential adverse effects and toxicity, and reducing the time and financial costs of drug development. The Way2Drug platform is intended for professionals engaged in the search and development of new medicines and must not be used by patients for making independent decisions regarding the use of medicinal products.
© 2011 - 2026 Way2Drug. All rights reserved.